NovaBridge Biosciences (NBP) Debt Ratio (2018 - 2023)
NovaBridge Biosciences (NBP) reported Debt Ratio of 0.01 for Q4 2023, up 146.49% year-over-year from 0.0 in Q4 2022, and up 29.81% on a QoQ basis from 0.01 in Q2 2023.
NovaBridge Biosciences (NBP) has 4 years of Debt Ratio data on file, last reported at 0.01 in Q4 2023.
- Quarterly Debt Ratio rose 146.49% year-over-year to 0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.01 (up 146.49% YoY) and the FY2023 annual result came in at 0.01, up 138.38% from the prior year.
- Debt Ratio improved to 0.01 in Q4 2023 per NBP's latest filing, from 0.01 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.03 in Q4 2019 and bottomed at 0.0 in Q4 2022.
- The 3-year median for Debt Ratio is 0.01 (2023), against an average of 0.01.
- The widest annual swing landed in 2019, when Debt Ratio decreased 14.54%; it then surged 146.49% in 2023.
- Tracing NBP's Debt Ratio over 3 years: stood at 0.03 in 2019, then plunged by 83.83% to 0.0 in 2022, then surged by 146.49% to 0.01 in 2023.
- Per Business Quant, the three latest NBP Debt Ratio figures stand at 0.01 (Q4 2023), 0.01 (Q2 2023), and 0.0 (Q4 2022).
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Dec 31, 2019 | 0.03 |
| Dec 31, 2018 | 0.03 |